Microinvasive gastric cancer

disease
On this page

Also known as early gastric cancerEGCsuperficial gastric cancersuperficial spreading gastric cancersurface gastric cancer

Summary

Microinvasive gastric cancer (MONDO:0001060) is a cancer and 74 clinical trials. Top therapeutic interventions include methylene blue cation, indocyanine green acid form, and amoxicillin. A subtype of gastric adenocarcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer
  • Clinical trials: 74

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namemicroinvasive gastric cancer
Mondo IDMONDO:0001060
DOIDDOID:10541
NCITC27131
SNOMED CT276809004
UMLSC0349530
MedGen138098
GARD0027565
Is cancer (heuristic)yes

Also known as: early gastric cancer · EGC · superficial gastric cancer · superficial spreading gastric cancer · surface gastric cancer

Disease family

This is a subtype of gastric adenocarcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorderdigestive system cancergastric cancergastric carcinomagastric adenocarcinomamicroinvasive gastric cancer

Related subtypes (8): gastric cardia adenocarcinoma, diffuse gastric adenocarcinoma, gastric intestinal type adenocarcinoma, gastric tubular adenocarcinoma, gastric papillary adenocarcinoma, mucinous gastric adenocarcinoma, signet ring cell gastric adenocarcinoma, CTNNA1-related diffuse gastric and lobular breast cancer syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 74.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified66
PHASE23
PHASE42
PHASE32
EARLY_PHASE11

Top trials by phase / activity

NCTPhaseStatusTitle
NCT07312370PHASE4NOT_YET_RECRUITINGEsomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
NCT01621451PHASE4UNKNOWNDoes Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?
NCT02407119PHASE3ACTIVE_NOT_RECRUITINGEffects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD
NCT04032119PHASE3COMPLETEDRCT of Gastric ESD With or Without Epineprhine Added Solution
NCT04973475PHASE2NOT_YET_RECRUITINGIndocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer
NCT01504997PHASE2UNKNOWNPhase II Study for Robot Assisted Distal Gastrectomy
NCT03837301PHASE2UNKNOWNNon-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2)
NCT02325999EARLY_PHASE1UNKNOWNEndoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection for Early Gastric Cancer
NCT02968069Not specifiedNOT_YET_RECRUITINGA Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions
NCT03857737Not specifiedNOT_YET_RECRUITINGEndoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer
NCT04665687Not specifiedRECRUITINGClinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients
NCT05291728Not specifiedRECRUITINGScreening for Early Gastric Cancer in Shaanxi Province
NCT05323929Not specifiedRECRUITINGThe Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma
NCT05978882Not specifiedNOT_YET_RECRUITINGFeasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)
NCT06389448Not specifiedRECRUITINGComparison of pCLE and EB in Gastric Lesion Diagnosis
NCT06748352Not specifiedRECRUITINGSafety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer
NCT06788548Not specifiedRECRUITINGFluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer(IDEAL Stage 2b)
NCT06962293Not specifiedRECRUITINGMagnetic Guided Counetrtraction During Endoscopic Submucosal Dissection
NCT07047937Not specifiedENROLLING_BY_INVITATIONExplainable Machine Learning for Predicting Early Gastric Cancer
NCT07253948Not specifiedRECRUITINGDistribution Characteristics of Helicobacter Pylori
NCT07295002Not specifiedNOT_YET_RECRUITINGSentinel Node Resection With or Without LECS After Noncurative ESD for EGC
NCT07401303Not specifiedNOT_YET_RECRUITINGFull-time RDI for ESD: Impact on Major Adverse Events and Procedure Time
NCT07405931Not specifiedRECRUITINGEvaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
NCT07486518Not specifiedNOT_YET_RECRUITINGA Multicentre Prospective Cohort Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India
NCT07507071Not specifiedNOT_YET_RECRUITINGComparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions
NCT07551466Not specifiedRECRUITINGAI Model for Early Gastric Cancer Diagnosis Using Endoscopic Imaging
NCT07615374Not specifiedACTIVE_NOT_RECRUITINGLaparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer
NCT01132469Not specifiedUNKNOWNEfficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer
NCT01364324Not specifiedCOMPLETEDPharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
NCT01435525Not specifiedCOMPLETEDNexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
NCT01544413Not specifiedCOMPLETEDQuality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer
NCT01643811Not specifiedCOMPLETEDEffect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients
NCT01659632Not specifiedUNKNOWNGastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer
NCT01688687Not specifiedCOMPLETEDConventional Biopsies vs pCLE for Diagnosis of Superficial Gastric Neoplasia
NCT01774266Not specifiedUNKNOWNDetection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer
NCT01804998Not specifiedCOMPLETEDMulticenter Phase III Trial of Laparoscopic Sentinel Node Biopsy
NCT01806753Not specifiedCOMPLETEDPerformance of Endoscopic Submucosal Dissection According to the Sedation Method
NCT01813994Not specifiedCOMPLETEDRole of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer
NCT01832246Not specifiedUNKNOWNEndoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer
NCT01921283Not specifiedCOMPLETEDMonitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
METHYLENE BLUE CATION43
INDOCYANINE GREEN ACID FORM42
AMOXICILLIN41
SUCRALFATE41
CARNOSINE32
REBAMIPIDE31
RACEPINEPHRINE21
CHEMBL236770601
CHEMBL170333601